Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microangiopathy after autologous HSCT in systemic sclerosis
NL-OMON46923Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jan 2017
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous hematopoietic stem cells in systemic sclerosis (SSc), sponsored by Leiden University Medical Center. Primary endpoints: Microangiopathy by nailfold capillary microscopy pattern, Capillary density and 5 more. Started Jan 2017; status: active, not recruiting.
02
Drugs
autologous hematopoietic stem cells
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NL-OMON46923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46923.